Ncardia Acquires STAR-CRISPR Technology for Advanced Gene Editing of iPSCs

Leveraging Rapid Analytics for Efficient Drug Development At Abzena, efficiency is a cornerstone of our drug development approach. We are committed to implementing strategies that maximize robustness and streamline our processes while ensuring the highest standards of quality. One of our key approaches is the use of platform strategies, which involve deploying well-studied, standardized methods an